Ethinylestradiol/desogestrel (EE/DSG), sold under the brand name Marvelon among others, is a fixed-dose combination of ethinylestradiol (EE), an estrogen, and desogestrel (DSG), a progestin, which is used as a birth control pill to prevent pregnancy in women.[2][3][5][6] It is taken by mouth.[3]
 Ethinylestradiol | |
 Desogestrel | |
| Combination of | |
|---|---|
| Ethinylestradiol | Estrogen |
| Desogestrel | Progestogen (Progestin) |
| Clinical data | |
| Trade names | Marvelon, Desogen, Ortho-cept, others |
| Other names | EE/DSG, EE-DSG, DSG+EE |
| AHFS/Drugs.com | Professional Drug Facts |
| MedlinePlus | a601050 |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
It was approved for medical use in the United Kingdom in 1981,[2] and in the United States in 1992.[3] In 2022, it was the 161st most commonly prescribed medication in the United States, with more than 3 million prescriptions.[7][8]
See also
editReferences
edit- ^ "Product monograph brand safety updates". Health Canada. 7 July 2016. Retrieved 3 April 2024.
- ^ a b c "Marvelon Tablets - Summary of Product Characteristics (SmPC)". (emc). 11 March 2021. Retrieved 18 June 2021.
- ^ a b c d "Desogen Tablets (desogestrel and ethinyl estradiol tablets USP)". DailyMed. 18 June 2018. Retrieved 18 June 2021.
- ^ "List of nationally authorised medicinal products" (PDF). European Medicines Agency.
- ^ Pundir J, Coomarasamy A (21 April 2016). Gynaecology: Evidence-Based Algorithms. Cambridge University Press. pp. 260–. ISBN 978-1-316-30110-4.
- ^ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 435, 436, 455, 459. ISBN 978-92-832-1291-1.
- ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
- ^ "Desogestrel; Ethinyl Estradiol Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |